Space Grown Insulin Crystals Provide New Data On Diabetes

June 03, 1998

Diabetic patients may someday reduce their insulin injections and lead more normal lives because of new insights gained through innovative space research in which the largest insulin crystals ever studied were grown on the Space Shuttle.

Results from a 1994 insulin crystal growth experiment in space are leading to a new understanding of diabetes -- a hormone deficiency disease. This has the potential to significantly reduce expensive treatments, since treatment of diabetes accounts for one-seventh of the nation's health care costs. Sixteen million Americans suffer from hormone deficiency diseases such as diabetes, hepatic failure, hemophilia, Parkinson and Huntington diseases.

"The space-grown insulin crystals have provided us new, never-before-seen information," said Dr. G. David Smith, scientist at Hauptman-Woodward Medical Research Institute, in Buffalo, N.Y. "As a result, we now have a much more detailed picture of insulin," Smith said.

Because of the increase in crystal size, Smith's team is able to study in more detail, the delicate balance of the insulin molecule. Natural insulin molecules hold together and gradually release into the human body. With some of the new and unexpected findings, researchers may be able to improve how insulin is released from its inactive-stored state to its active state. This could greatly improve the quality-of-life of people who are on insulin therapy by cutting down on the number of injections they have to take.

"This new information can be used in the development of a new therapeutic insulin treatment for the control of diabetes," said Smith. Hauptman-Woodward is partnering with the Center for Macromolecular Crystallography, a NASA Commercial Space Center, in Birmingham, Ala.

"We are doing crystal growth experiments in the near-weightlessness of space that really tell the story of how insulin works and give us clues of how, in the long run, to defeat diabetes," said Dr. Marianna M. Long, associate director of the center located at the University of Alabama at Birmingham.

Insulin is one of the most important hormones in the human body because it regulates the body's blood sugar levels. In people with diabetes, insulin is not produced in sufficient quantity, nor regulated properly. This metabolism disorder impairs the body's ability to use digested food for growth and energy.

Current treatment is to inject the insulin hormone. However, the peaks and valleys in insulin levels can lead to serious health problems, including blindness, lack of circulation, limb amputations and kidney failure.

Like many chemicals in the body, the three-dimensional structure of insulin is extremely complex. The intricate, blueprint-like arrangement of atoms within the insulin molecule determines how well the hormone interacts within the body. When grown on the ground, insulin crystals do not grow as large or as ordered as researchers desire -- obscuring the blueprint of the insulin molecules.

The center in Birmingham is one of NASA's 10 Commercial Space Centers managed by the Space Product Development Office within the Microgravity Research Program Office at NASA's Marshall Space Flight Center in Huntsville, Ala. Each center represents a NASA partnership with industry and academia, pursuing product-oriented research in areas such as biotechnology, agriculture and materials. Unique research opportunities of the space environment are made available to encourage private industries to exploit the benefits of space-based research to develop new products or services.

NASA research has furthered the understanding of many diseases, including AIDS, heart disease, cancer, respiratory syncytial virus, sickle cell anemia, hepatitis and rheumatoid arthritis.
-end-
Note to Editors: Interviews with NASA, industry and university researchers are available via telephone, NASA/TV live satellite link or e-mail. Please contact NASA representative Steve Roy of the Marshall Center Media Relations Office at (256)544-6535.

More information about NASA Space Products Development Office is available on the World Wide Web at: http://microgravity.msfc.nasa.gov/MICROGRAVITY/SPD.html

Photos: Contact Steve Roy to receive the four available photos or download print-quality images from the web at: http://www.msfc.nasa.gov/upload/pao/1998files/98-079.html
(Molecule diagram from Earth-grown crystals):
Like many chemicals in the body, the three-dimensional structure of insulin is extremely complex. When grown on the ground, insulin crystals do not grow as large or as ordered as researchers desire -- obscuring the blueprint of the insulin molecules.
-end-


NASA/Marshall Space Flight Center News Center

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.